PSA PET Scan: PSMA Imaging for Rising PSA
Share
For prostate cancer patients with rising PSA after primary treatment (surgery or radiation), PSMA PET-CT is now the standard imaging modality. It replaces older techniques (bone scan, CT, choline PET) with substantially better sensitivity at low PSA levels. This light guide explains when and how to use PSMA PET for PSA monitoring.
What "PSA PET" Means
The term "PSA PET" is slightly imprecise — there's no tracer called PSA. What's meant is a PET-CT scan ordered to investigate rising PSA, typically using a PSMA-targeted tracer:
- Ga-68 PSMA-11
- F-18 DCFPyL (Pylarify)
- F-18 PSMA-1007 (European)
These tracers target prostate-specific membrane antigen on prostate cancer cells, not PSA itself (which is a serum marker).
When to Order PSMA PET
For prostate cancer patients with rising PSA:
- After radical prostatectomy: PSA should be undetectable. Rising PSA = biochemical recurrence. PSMA PET ordered at PSA 0.2-0.5 ng/mL.
- After radiation therapy: PSA nadir + 2 (or PSA >2 absolute) defines biochemical failure. PSMA PET helps localize.
- Hormone therapy failure: rising PSA despite ADT. PSMA PET helps map progression.
For initial staging of new prostate cancer (unfavorable intermediate or high-risk features), PSMA PET is increasingly standard.
Sensitivity by PSA Level
| PSA level | PSMA PET detection rate |
|---|---|
| <0.2 ng/mL | 25-35% |
| 0.2-0.5 | 40-55% |
| 0.5-1.0 | 60-75% |
| 1.0-2.0 | 80-90% |
| 2.0-5.0 | 90-95% |
| 5.0+ | 95%+ |
The increase between PSA 0.5 and 2.0 is steep — many physicians wait until PSA reaches 0.5-1.0 before ordering PSMA to maximize yield.
What PSMA PET Detects
Sites of recurrence visualizable:
- Prostate bed (after surgery)
- Pelvic lymph nodes
- Retroperitoneal lymph nodes
- Bone (lytic and sclerotic metastases)
- Distant lymph nodes
- Visceral organs (less common in prostate cancer)
PSMA PET is significantly more sensitive than CT + bone scan combined.
For PSA monitoring and PSMA PET interpretation, our team can help.
What Changes After PSMA PET
The clinical implications of PSMA findings:
- Localized recurrence (prostate bed): salvage radiation
- Single nodal recurrence: stereotactic radiotherapy
- Multiple nodal recurrences: pelvic radiation field, possibly with hormone therapy
- Distant metastases: systemic therapy, consideration of theranostic Lu-177 PSMA
PSMA findings change management in 50-70% of biochemical recurrence cases.
Cost
Cash prices for PSMA PET in various locations:
- US: $5,000-7,500
- US (Medicare allowed): $3,500-5,500
- UK private: £2,500-4,500
- Hong Kong: HKD 18,000-28,000
- Singapore: SGD 4,500-6,500
- Mainland China (top centers): ¥10,000-15,000 ($1,430-2,140)
Top Chinese centers: PUMC Beijing, Fudan Shanghai Cancer Center, Sun Yat-sen Cancer Center Guangzhou, Ruijin Hospital Shanghai, HKU-Shenzhen.
Pre-Scan Preparation
PSMA PET requires no fasting and no special diet. Pre-scan steps:
- Hydration encouraged
- No bowel prep
- Routine blood work (PSA, CBC, basic metabolic)
- Recent images (prior MRI of prostate, recent CT, prior PSMA PET) for comparison
Frequently Asked Questions
At what PSA should I get PSMA PET?
Most guidelines recommend at PSA 0.2-0.5 after surgery; at clinical concern after radiation. Detection rate increases steeply above 0.5.
Is PSMA PET safe to repeat?
Yes. Radiation dose 4-8 mSv per scan. Repeat scans over years are well-tolerated; cumulative dose is small.
Will my insurance pay?
US Medicare and most major commercial insurers cover PSMA PET for confirmed prostate cancer staging or biochemical recurrence. Prior authorization sometimes required.
Can I get PSMA PET in China?
Yes. Wait time typically 3-10 business days at top centers. Cash price ¥10,000-15,000.
Need Help Booking?
SinoCareLink can pre-book PSMA PET at a top Chinese hospital, coordinate urology consults, translate reports into English, and arrange airport pickup. Contact us for a free consultation.